Abiopharma

🔍 McBee Brannin (Executive)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Sold 28 shares of Class A Common Stock at $107.0546 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,972.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 31 shares of Class A Common Stock at $108.2458 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,941.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 40 shares of Class A Common Stock at $109.2088 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,901.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
• Sold 97 shares of Class A Common Stock at $110.2765 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,804.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3
• Sold 160 shares of Class A Common Stock at $111.2297 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,644.00 | transaction_form_type: 4 | Footnotes: F1, F7, F3
• Sold 53 shares of Class A Common Stock at $112.0389 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,591.00 | transaction_form_type: 4 | Footnotes: F1, F8, F3
• Sold 22 shares of Class A Common Stock at $112.9545 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,569.00 | transaction_form_type: 4 | Footnotes: F1, F9, F3
• Sold 18 shares of Class A Common Stock at $114.4978 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,551.00 | transaction_form_type: 4 | Footnotes: F1, F10, F3
• Sold 20 shares of Class A Common Stock at $115.444 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,531.00 | transaction_form_type: 4 | Footnotes: F1, F11, F3
• Sold 23 shares of Class A Common Stock at $116.4843 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,508.00 | transaction_form_type: 4 | Footnotes: F1, F12, F3
• Sold 4 shares of Class A Common Stock at $117.3875 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,504.00 | transaction_form_type: 4 | Footnotes: F1, F13, F3
• Sold 4 shares of Class A Common Stock at $119.0 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,500.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-22 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 1,800.00 | Footnotes: F14
• Holds 108,600 shares of Class B Common Stock (Derivative)
  Date: 2026-06-22 | Code: H | shares_owned_after: 108,600.00 | Footnotes: F15, F15, F15, F16
• Holds 1,582,773 shares of Class B Common Stock (Derivative)
  Date: 2026-06-22 | Code: H | shares_owned_after: 1,582,773.00 | Footnotes: F15, F15, F15, F17
• Holds 122,000 shares of Class B Common Stock (Derivative)
  Date: 2026-06-22 | Code: H | shares_owned_after: 122,000.00 | Footnotes: F15, F15, F15, F18
• Holds 263,795 shares of Class B Common Stock (Derivative)
  Date: 2026-06-22 | Code: H | shares_owned_after: 263,795.00 | Footnotes: F15, F15, F15, F19

Footnotes:

• F1: The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.63 to $107.62, inclusive.
• F3: The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.66 to $108.65, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.66 to $109.65, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.66 to $110.65, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.66 to $111.65, inclusive.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.66 to $112.65, inclusive.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.67 to $113.58, inclusive.
• F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.94 to $114.89, inclusive.
• F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.99 to $115.98, inclusive.
• F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.99, inclusive.
• F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.05 to $117.76, inclusive.
• F14: The reported securities are directly held of record by the reporting person's child.
• F15: Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
• F16: The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.
• F17: The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.
• F18: The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.
• F19: The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.
• REMARKS: This Form 4 is Part 4 of 4 for this reporting person. Transactions by the reporting person are continued on this Part 4.